US Stock MarketDetailed Quotes

AKTX Akari Therapeutics

Watchlist

3.3200
+0.0500+1.53%

Close Sep 17 16:00 ET

40.32MMarket Cap-1128P/E (TTM)

Akari Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

(Q4)Dec 31, 2021

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

20.37%5.56M

30.37%5.99M

-27.21%16.81M

-20.65%4.62M

-12.39%4.59M

34.12%23.09M

34.32%5.82M

-5.49%5.24M

-4.26%17.21M

-14.84%5.87M

Selling and administrative expenses

-27.50%2.24M

29.58%3.71M

-16.05%11.36M

4.25%3.09M

-7.78%2.86M

67.40%13.53M

38.12%2.97M

53.74%3.1M

-11.79%8.08M

-9.58%2.02M

-General and administrative expense

-27.50%2.24M

29.58%3.71M

-16.05%11.36M

4.25%3.09M

-7.78%2.86M

67.40%13.53M

38.12%2.97M

53.74%3.1M

-11.79%8.08M

-9.58%2.02M

Research and development costs

117.45%3.31M

31.66%2.28M

-43.00%5.45M

-46.55%1.52M

-19.10%1.73M

4.68%9.56M

30.58%2.85M

-39.38%2.14M

3.55%9.13M

-17.37%3.85M

Operating profit

-20.37%-5.56M

-30.37%-5.99M

27.21%-16.81M

20.65%-4.62M

12.39%-4.59M

-34.12%-23.09M

-34.32%-5.82M

5.49%-5.24M

4.26%-17.21M

14.84%-5.87M

Net non-operating interest income expense

-268.97%-49K

-93.33%2K

78.26%82K

633.25%29K

587.76%30K

333.96%46K

161.06%3.96K

16.79%4.36K

-22.14%10.6K

-25.22%3.98K

Non-operating interest income

-93.10%2K

-93.33%2K

78.26%82K

633.25%29K

587.76%30K

333.96%46K

161.06%3.96K

16.79%4.36K

-22.14%10.6K

-25.22%3.98K

Non-operating interest expense

--51K

----

--0

----

Other net income (expense)

-433.45%-1.95M

-92.43%421K

26.86%6.72M

343.20%586K

8,701.48%5.57M

2,498.72%5.29M

840.76%132.22K

121.54%63.23K

-124.92%-220.7K

-0.37%80.04K

Gain on sale of security

-110.02%-60K

-92.41%423K

23.90%6.74M

323.55%599K

7,827.55%5.58M

2,913.39%5.44M

1,208.86%141.42K

124.61%70.34K

-121.29%-193.22K

-1.58%91.17K

Special income (charges)

---1.89M

----

--0

----

-Less：Restructuring and merger&acquisition

--1.89M

----

--0

----

Other non- operating income (expenses)

----

81.82%-2K

86.62%-19K

-41.23%-13K

-54.73%-11K

-416.70%-142K

-80.67%-9.21K

7.82%-7.11K

-24.88%-27.48K

9.49%-11.12K

Income before tax

-88.95%-7.56M

-656.04%-5.57M

43.61%-10.01M

29.58%-4M

119.34%1M

-1.86%-17.75M

-30.68%-5.68M

11.34%-5.18M

-2.01%-17.42M

15.00%-5.79M

Income tax

Net income

-88.95%-7.56M

-656.04%-5.57M

43.61%-10.01M

29.58%-4M

119.34%1M

-1.86%-17.75M

-30.68%-5.68M

11.34%-5.18M

-2.01%-17.42M

15.00%-5.79M

Net income continuous Operations

-88.95%-7.56M

-656.04%-5.57M

43.61%-10.01M

29.58%-4M

119.34%1M

-1.86%-17.75M

-30.68%-5.68M

11.34%-5.18M

-2.01%-17.42M

15.00%-5.79M

Minority interest income

Net income attributable to the parent company

-88.95%-7.56M

-656.04%-5.57M

43.61%-10.01M

29.58%-4M

119.34%1M

-1.86%-17.75M

-30.68%-5.68M

11.34%-5.18M

-2.01%-17.42M

15.00%-5.79M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-88.95%-7.56M

-656.04%-5.57M

43.61%-10.01M

29.58%-4M

119.34%1M

-1.86%-17.75M

-30.68%-5.68M

11.34%-5.18M

-2.01%-17.42M

15.00%-5.79M

Basic earnings per share

-1.46%-0.8025

-408.94%-0.8275

64.03%-2.0447

58.68%-0.7909

113.86%0.2678

29.98%-5.6853

15.28%-1.9141

36.34%-1.9321

59.40%-8.1192

82.01%-2.4904

Diluted earnings per share

-1.46%-0.8025

-413.03%-0.8275

64.03%-2.0447

58.68%-0.7909

113.68%0.2643

29.98%-5.6853

15.28%-1.9141

36.34%-1.9321

59.40%-8.1192

82.01%-2.4904

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021	(Q4)Dec 31, 2021
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	20.37%5.56M	30.37%5.99M	-27.21%16.81M	-20.65%4.62M	-12.39%4.59M	34.12%23.09M	34.32%5.82M	-5.49%5.24M	-4.26%17.21M	-14.84%5.87M
Selling and administrative expenses	-27.50%2.24M	29.58%3.71M	-16.05%11.36M	4.25%3.09M	-7.78%2.86M	67.40%13.53M	38.12%2.97M	53.74%3.1M	-11.79%8.08M	-9.58%2.02M
-General and administrative expense	-27.50%2.24M	29.58%3.71M	-16.05%11.36M	4.25%3.09M	-7.78%2.86M	67.40%13.53M	38.12%2.97M	53.74%3.1M	-11.79%8.08M	-9.58%2.02M
Research and development costs	117.45%3.31M	31.66%2.28M	-43.00%5.45M	-46.55%1.52M	-19.10%1.73M	4.68%9.56M	30.58%2.85M	-39.38%2.14M	3.55%9.13M	-17.37%3.85M
Operating profit	-20.37%-5.56M	-30.37%-5.99M	27.21%-16.81M	20.65%-4.62M	12.39%-4.59M	-34.12%-23.09M	-34.32%-5.82M	5.49%-5.24M	4.26%-17.21M	14.84%-5.87M
Net non-operating interest income expense	-268.97%-49K	-93.33%2K	78.26%82K	633.25%29K	587.76%30K	333.96%46K	161.06%3.96K	16.79%4.36K	-22.14%10.6K	-25.22%3.98K
Non-operating interest income	-93.10%2K	-93.33%2K	78.26%82K	633.25%29K	587.76%30K	333.96%46K	161.06%3.96K	16.79%4.36K	-22.14%10.6K	-25.22%3.98K
Non-operating interest expense	--51K	----	----	--0	----	----	----	----	----	----
Other net income (expense)	-433.45%-1.95M	-92.43%421K	26.86%6.72M	343.20%586K	8,701.48%5.57M	2,498.72%5.29M	840.76%132.22K	121.54%63.23K	-124.92%-220.7K	-0.37%80.04K
Gain on sale of security	-110.02%-60K	-92.41%423K	23.90%6.74M	323.55%599K	7,827.55%5.58M	2,913.39%5.44M	1,208.86%141.42K	124.61%70.34K	-121.29%-193.22K	-1.58%91.17K
Special income (charges)	---1.89M	----	----	--0	----	----	----	----	----	----
-Less：Restructuring and merger&acquisition	--1.89M	----	----	--0	----	----	----	----	----	----
Other non- operating income (expenses)	----	81.82%-2K	86.62%-19K	-41.23%-13K	-54.73%-11K	-416.70%-142K	-80.67%-9.21K	7.82%-7.11K	-24.88%-27.48K	9.49%-11.12K
Income before tax	-88.95%-7.56M	-656.04%-5.57M	43.61%-10.01M	29.58%-4M	119.34%1M	-1.86%-17.75M	-30.68%-5.68M	11.34%-5.18M	-2.01%-17.42M	15.00%-5.79M
Income tax
Net income	-88.95%-7.56M	-656.04%-5.57M	43.61%-10.01M	29.58%-4M	119.34%1M	-1.86%-17.75M	-30.68%-5.68M	11.34%-5.18M	-2.01%-17.42M	15.00%-5.79M
Net income continuous Operations	-88.95%-7.56M	-656.04%-5.57M	43.61%-10.01M	29.58%-4M	119.34%1M	-1.86%-17.75M	-30.68%-5.68M	11.34%-5.18M	-2.01%-17.42M	15.00%-5.79M
Minority interest income
Net income attributable to the parent company	-88.95%-7.56M	-656.04%-5.57M	43.61%-10.01M	29.58%-4M	119.34%1M	-1.86%-17.75M	-30.68%-5.68M	11.34%-5.18M	-2.01%-17.42M	15.00%-5.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-88.95%-7.56M	-656.04%-5.57M	43.61%-10.01M	29.58%-4M	119.34%1M	-1.86%-17.75M	-30.68%-5.68M	11.34%-5.18M	-2.01%-17.42M	15.00%-5.79M
Basic earnings per share	-1.46%-0.8025	-408.94%-0.8275	64.03%-2.0447	58.68%-0.7909	113.86%0.2678	29.98%-5.6853	15.28%-1.9141	36.34%-1.9321	59.40%-8.1192	82.01%-2.4904
Diluted earnings per share	-1.46%-0.8025	-413.03%-0.8275	64.03%-2.0447	58.68%-0.7909	113.68%0.2643	29.98%-5.6853	15.28%-1.9141	36.34%-1.9321	59.40%-8.1192	82.01%-2.4904
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	Unqualified Opinion with Explanatory Notes	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data